Skip to content
Brand AI

Orbis

Recent events

Recent events tied to this brand in public sources.

Back to profile2 entries

  1. 2026

    Novo and Orbis sign deal worth up to $1.4 billion to develop oral drugs

    Novo and Orbis signed a deal worth up to $1.4 billion to develop oral drugs.

    Source

  2. 2020

    Accor sold its majority stake in Orbis

    Accor sold 85.8% of Orbis to AccorInvest for €1.06 billion on March 11, 2020.

    Source